Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
Primary Purpose
Cystic Fibrosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tele-exercise
Sponsored by
About this trial
This is an interventional other trial for Cystic Fibrosis
Eligibility Criteria
Inclusion Criteria
- 8 - 21 years old
- Diagnosis of Cystic Fibrosis confirmed by genetic studies and/or sweat chloride testing
- Baseline pulmonary function testing (PFT) (within the last 3 months) with FEV1 (Forced expiratory volume in 1 second) > 40%
- Must be able to perform 3-minute step test.
- Must achieve an adequate 15 count breathlessness score. Must be able to perform ergometry testing utilizing extremities
- Must have a working computer/smartphone/tablet with internet connection at home
Exclusion criteria
- FEV1 < 40%
- Desaturations (less than 75%) or significant fatigue with 3-minute step test 15 count breathlessness score of greater than 2
- Pulmonary exacerbation (shortness of breath or difficulty breathing requiring hospitalization) within the last 4 weeks
- Oxygen requirement at rest or during sleeping.
- Recent pneumothorax (popped lung) within last 3 months
- Moderate pulmonary hypertension (increased pressure in the lung arteries) diagnosed via echocardiogram.
- History of low ejection fraction (percentage of blood being pumped out of the heart) via echocardiogram.
- History of cardiac ischemia (reduced blood supply to heart tissue).
- Uncontrolled systemic hypertension for patient age and height.
- Moderate to severe scoliosis (abnormal curvature of the spine)
Sites / Locations
- Pediatric Exercise and Genomics Research Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Cystic fibrosis patients
Arm Description
Receive tele-exercise training and undergo pulmonary function testing and exercise testing
Outcomes
Primary Outcome Measures
Habitual activity
An Actigraph accelerometer will be worn by the participant during waking hours for the first week and last week of the exercise program to assess habitual activity.
Secondary Outcome Measures
Peak oxygen consumption
The patient will exercise on a cycle ergometer, using a ramp protocol in which the resistance is increased by 10-20 watts per minute, until exhaustion. During this test, breath by breath measurements of physiological parameters (oxygen saturation, carbon dioxide levels, respiratory rate, heart rate) will be measured. From these measurements, we will extrapolate VO2 (oxygen consumption) at its peak, which is when the participant reaches his or her highest level of exertion.
Cystic fibrosis quality of life survey
Approximately 50 questions related to quality of life in Cystic fibrosis.
System usability survey
A ten question survey related to system usability. Answers for these questions range from 0 (strongly disagree) to 4 (strongly agree)
Full Information
NCT ID
NCT02715921
First Posted
January 12, 2016
Last Updated
August 13, 2020
Sponsor
MemorialCare Health System
Collaborators
University of California, Irvine
1. Study Identification
Unique Protocol Identification Number
NCT02715921
Brief Title
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
Official Title
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
April 25, 2019 (Actual)
Study Completion Date
May 7, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MemorialCare Health System
Collaborators
University of California, Irvine
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Fitness in patients with Cystic fibrosis (CF) is an important biomarker associated with higher survivability and improved quality of life. CF patients are encouraged to maintain an active lifestyle, however, while physicians are able to prescribe airway clearance measures or specific medications, there is no prescription for exercise or avenue to promote exercise outside the clinic or hospital.
Detailed Description
The advent of ubiquitous computing has transformed the landscape of healthcare delivery. Thus far, exercise training in CF have either required patients travel to a gym or relied on home visits or telephone calls. Virtual visits provide a novel and innovative platform to deliver a live stream of exercise sessions with two-way video and audio capabilities, allowing individualized attention to exercise for CF patient from the comfort and privacy of their homes. Applications of tele-exercise, or tele-rehabilitation, have been shown to be as effective as in conventional physical therapy following orthopedic surgeries and, in stroke patients, to optimize patient outcome by prolonging duration of treatment and preventing the observed decline after the termination of therapy. For CF patients, the latter is especially important given the impact of hospitalizations for acute exacerbations on exercise tolerance. In this particular population, where cross-contamination risks limit use of group exercise activity, using two-way video telecommunication allows participation in exercise programs while adhering to the standards of CF management regarding infection control.
This study would be the first to evaluate implementing tele-exercise and remote monitoring program on pediatric CF patients. Pediatric CF patients will be enrolled in a six-week exercise program that is streamed live from an instructor into their computers at home via a HIPAA compliant telemedicine platform. Remote monitoring devices, such as accelerometers and wireless heart rate monitors, will evaluate baseline habitual activity and intensity of exercise, respectively. The goal of this study is to show that tele-exercise program is a feasible and convenient and cost-effective method to enhance CF care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cystic fibrosis patients
Arm Type
Experimental
Arm Description
Receive tele-exercise training and undergo pulmonary function testing and exercise testing
Intervention Type
Other
Intervention Name(s)
Tele-exercise
Primary Outcome Measure Information:
Title
Habitual activity
Description
An Actigraph accelerometer will be worn by the participant during waking hours for the first week and last week of the exercise program to assess habitual activity.
Time Frame
7 days
Secondary Outcome Measure Information:
Title
Peak oxygen consumption
Description
The patient will exercise on a cycle ergometer, using a ramp protocol in which the resistance is increased by 10-20 watts per minute, until exhaustion. During this test, breath by breath measurements of physiological parameters (oxygen saturation, carbon dioxide levels, respiratory rate, heart rate) will be measured. From these measurements, we will extrapolate VO2 (oxygen consumption) at its peak, which is when the participant reaches his or her highest level of exertion.
Time Frame
30 minutes
Title
Cystic fibrosis quality of life survey
Description
Approximately 50 questions related to quality of life in Cystic fibrosis.
Time Frame
50 minutes
Title
System usability survey
Description
A ten question survey related to system usability. Answers for these questions range from 0 (strongly disagree) to 4 (strongly agree)
Time Frame
10 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria
8 - 21 years old
Diagnosis of Cystic Fibrosis confirmed by genetic studies and/or sweat chloride testing
Baseline pulmonary function testing (PFT) (within the last 3 months) with FEV1 (Forced expiratory volume in 1 second) > 40%
Must be able to perform 3-minute step test.
Must achieve an adequate 15 count breathlessness score. Must be able to perform ergometry testing utilizing extremities
Must have a working computer/smartphone/tablet with internet connection at home
Exclusion criteria
FEV1 < 40%
Desaturations (less than 75%) or significant fatigue with 3-minute step test 15 count breathlessness score of greater than 2
Pulmonary exacerbation (shortness of breath or difficulty breathing requiring hospitalization) within the last 4 weeks
Oxygen requirement at rest or during sleeping.
Recent pneumothorax (popped lung) within last 3 months
Moderate pulmonary hypertension (increased pressure in the lung arteries) diagnosed via echocardiogram.
History of low ejection fraction (percentage of blood being pumped out of the heart) via echocardiogram.
History of cardiac ischemia (reduced blood supply to heart tissue).
Uncontrolled systemic hypertension for patient age and height.
Moderate to severe scoliosis (abnormal curvature of the spine)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jen Jen Chen, MD
Organizational Affiliation
MemorialCare
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pediatric Exercise and Genomics Research Center
City
Irvine
State/Province
California
ZIP/Postal Code
92697
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study
We'll reach out to this number within 24 hrs